[DPHARMA] YoY Quarter Result on 31-Dec-2023 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-Feb-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
31-Dec-2023 [#4]
Profit Trend
QoQ- -5.22%
YoY- -50.46%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 167,501 151,960 145,444 134,086 137,755 115,634 112,253 6.89%
PBT 7,034 15,347 17,128 20,471 13,939 17,658 12,825 -9.52%
Tax 1,468 1,814 -1,412 -4,278 -1,906 -3,289 -1,057 -
NP 8,502 17,161 15,716 16,193 12,033 14,369 11,768 -5.27%
-
NP to SH 8,502 17,161 15,716 16,193 12,033 14,369 11,870 -5.40%
-
Tax Rate -20.87% -11.82% 8.24% 20.90% 13.67% 18.63% 8.24% -
Total Cost 158,999 134,799 129,728 117,893 125,722 101,265 100,485 7.94%
-
Net Worth 682,979 657,045 621,564 642,484 525,364 483,173 479,809 6.05%
Dividend
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Div 17,314 17,140 16,951 42,361 34,114 26,475 16,737 0.56%
Div Payout % 203.66% 99.88% 107.86% 261.60% 283.51% 184.25% 141.01% -
Equity
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Net Worth 682,979 657,045 621,564 642,484 525,364 483,173 479,809 6.05%
NOSH 961,942 952,239 941,765 706,026 684,383 661,881 278,959 22.90%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 5.08% 11.29% 10.81% 12.08% 8.74% 12.43% 10.48% -
ROE 1.24% 2.61% 2.53% 2.52% 2.29% 2.97% 2.47% -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 17.41 15.96 15.44 18.99 20.19 17.47 40.24 -13.02%
EPS 0.88 1.80 1.67 2.29 1.76 2.17 4.22 -22.98%
DPS 1.80 1.80 1.80 6.00 5.00 4.00 6.00 -18.17%
NAPS 0.71 0.69 0.66 0.91 0.77 0.73 1.72 -13.70%
Adjusted Per Share Value based on latest NOSH - 961,942
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 17.41 15.80 15.12 13.94 14.32 12.02 11.67 6.89%
EPS 0.88 1.78 1.63 1.68 1.25 1.49 1.23 -5.42%
DPS 1.80 1.78 1.76 4.40 3.55 2.75 1.74 0.56%
NAPS 0.71 0.683 0.6462 0.6679 0.5461 0.5023 0.4988 6.05%
Price Multiplier on Financial Quarter End Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 29/12/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 -
Price 1.26 1.61 1.68 3.38 1.42 0.95 2.53 -
P/RPS 7.24 10.09 10.88 17.80 7.03 5.44 6.29 2.37%
P/EPS 142.56 89.34 100.67 147.37 80.52 43.76 59.46 15.68%
EY 0.70 1.12 0.99 0.68 1.24 2.29 1.68 -13.57%
DY 1.43 1.12 1.07 1.78 3.52 4.21 2.37 -8.07%
P/NAPS 1.77 2.33 2.55 3.71 1.84 1.30 1.47 3.14%
Price Multiplier on Announcement Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 22/02/24 23/02/23 15/02/22 22/02/21 13/02/20 18/02/19 28/02/18 -
Price 1.21 1.65 1.60 3.42 1.64 1.03 2.97 -
P/RPS 6.95 10.34 10.36 18.01 8.12 5.90 7.38 -0.99%
P/EPS 136.90 91.56 95.88 149.11 92.99 47.45 69.80 11.87%
EY 0.73 1.09 1.04 0.67 1.08 2.11 1.43 -10.59%
DY 1.49 1.09 1.13 1.75 3.05 3.88 2.02 -4.94%
P/NAPS 1.70 2.39 2.42 3.76 2.13 1.41 1.73 -0.29%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment